Background
Greg Williams advises and conducts litigation for clients operating in the pharmaceutical and medical devices industries. His science qualifications and laboratory experience give him a special insight into and understanding of his clients' commercial imperatives and legal needs.
Greg's experience ranges from acting in large-scale product liability class actions and commercial litigation to advising on regulatory issues, advertising and labelling requirements, and product safety issues.
In the regulatory sphere, Greg advises numerous Australian and overseas pharmaceutical and medical device clients on all aspects of the product life cycle, including regulatory and contractual arrangements for clinical trials, privacy, product registration and reimbursement, advertising disputes, and product safety and recalls. Greg's role extends to assisting these clients with managing risk and exposure under the US Foreign Corrupt Practices Act (FCPA).
